Search

everythinglearnresearchcommunity

for

Search:↓

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Skin diseases differ between Ghana and the UK, with infections most common in Ghana and malignant skin diseases most prevalent in the UK.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Baricitinib is effective and safe for treating severe alopecia areata.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Micro-needling effectively improves wrinkles, scars, and hair growth, but proper technique and safety are important.

These skin conditions in African men need combined medical treatments and lifestyle changes.